Navigation Links
Young researcher on the trail of herbal snakebite antidote
Date:9/17/2012

A PhD student at the University of Copenhagen has drawn on nature's own pharmacy to help improve the treatment of snakebites in Africa.

Marianne Molander from the University of Copenhagen's Faculty of Health and Medical Sciences has been working within a Danish team that has examined various plants native to the African continent in a bid to find locally available herbal antidotes.

"Snake venom antidotes are expensive, it's often a long way to the nearest doctor and it can be difficult to store the medicine properly in the warm climate. As a result many local people rely on natural resources for treating potentially fatal bites," says pharmacist and PhD student Marianne Molander.

The Danish researchers are now investigating African plants that have proven effective in treating snakebite. Armed with the results of their research they are set to provide guidance in the use of plants in remote areas where local people have limited access to Western medicine:

"We have particularly focused on the snake species Bitis arietans, which is widespread south of the Sahara. All snake venoms consist of a unique cocktail of enzymes, which results in rapid tissue death. Along with our African partners, we are currently testing plants that act as venom antidotes in remote regions of Africa. A hundred plants from Mali, 27 from South Africa and 13 from the Democratic Republic of Congo are now under the microscope," says Marianne Molander, PhD student in drug design and pharmacology at the University of Copenhagen.

Snake venom as medicine

100,000 people worldwide die each year from snakebites. Three times as many suffer permanent injuries, disability or amputations as a result of a bite to an arm or leg. The problem is greatest in tropical developing countries, where agricultural workers, women and children are the most likely victims. Although a million people in Africa are bitten by snakes each year - only half receive treatment.

But snake venom is not all bad. There are many instances where venom can be developed into drugs used, for example, in the treatment of hypertension, heart failure and diabetic kidney disease. The drug Aggrastat, which is used for chest pain, was developed using a peptide from an African viper.

Herbal healing in Africa

Historically plants have always been a major source of drugs. A quarter of all new medicinal products registered worldwide, come from plants or other natural resources. This impressive potential has its origins in the fact that plants have evolved to contain substances that prevent them being eaten or attacked by diseases. These biologically active defence compounds can sometimes be useful for developing new drugs. And Africa's poor use nature as their medicine cabinet.

"In Africa where much of the population can't afford medicine, there is a tradition of seeking out healers and alternative therapists, before turning to conventional medicine. Eighty percent visit the healer before they go to the hospital. Traditional herbal medicine is based on centuries of traditions and achievement, so the local shamans and medicine men are often a good place to start when you are looking for active substances with real pharmaceutical effects," says Marianne Molander.


'/>"/>

Contact: Marianne Molander
mmo@sund.ku.dk
(45) 61-18-56-33
University of Copenhagen
Source:Eurekalert

Related medicine news :

1. How is grief unique to young adults with cancer?
2. Younger Kids Likelier to Gain Weight After Tonsillectomy
3. Young Children Treated for Cancer May Be at Risk for PTSD: Study
4. Earlier treatment for young patients with chronic hepatitis B more effective in clearing virus
5. Almost 1 in 5 young children with cancer suffers from a trauma disorder
6. Magazines jeopardize and empower young womens sexuality
7. Parents and readers beware of stereotypes in young adult literature
8. Close contact with young people at risk of suicide has no effect
9. ADHD May Raise Girls Risk for Suicide as Young Adults
10. For young adults, appearance matters more than health, MU research suggests
11. Study links persistent and loud snoring in young children with problem behaviors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... TransWipe Volume 3 is a ... Drag and drop a TransWipe preset between two video clips to instantly add a ... to colored panels with customizable color and orientation options. TransWipe Volume 3 is a ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , ... a development collaboration with the Australian critical medicine company, Phebra Pty Ltd. ... , LAI medicines can offer improved therapeutic benefits over oral formulations, including better ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Einstein Medical ... Twitter feed to cover the latest news and commentary at the 2016 ASCRS/ASOA Symposium ... meeting of the American Society of Cataract and Refractive Surgery and the American Society ...
(Date:5/5/2016)... , ... May 05, 2016 , ... This weekend, from Friday, May 6 - Sunday, ... steep California terrain at the first Team Semper Fi Mountain Bike Camp, hosted in conjunction ... be mountain bike legends Mark Weir and Jason Moeschler, who’ll share pro tips with the ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... the Wharton Seminars for Business Journalists , led by the Wharton ... business and economic issues.  This one-day program at the Wharton School’s San ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... Research and Markets has announced the addition ... EU Markets"  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... the current Positron Emission Tomography (PET) scanner and cyclotron install ... includes France , Germany ... and the United Kingdom . Along ...
(Date:5/4/2016)... Holdings (NYSE: CODI ) ("CODI," "we," "our" ... businesses, announced today its consolidated operating results for the ... Quarter 2016 Highlights , Generated Cash Flow Available ... $13.6 million for the first quarter of 2016; ... first quarter of 2016; , Paid a first ...
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
Breaking Medicine Technology: